Readmissions and the quality of care in patients hospitalized with heart failure

International Journal for Quality in Health Care

Volumn 15, Issue 5, 2003, Pages 413-421

  Luthi, Jean Christophe ^a,b,c   Lund, Mary Jo ^b   Sampietro Colom, Laura ^b,c,d   Kleinbaum, David G ^b   Ballard, David J ^e   McClellan, William M ^b,f  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EMORY UNIVERSITY   (United States)

^c Kerr L White Inst Hlth Serv Res   (United States)

^d Catalan Agency for Health Technology Assessment and Research   (Spain)

^e BAYLOR HEALTH CARE SYSTEM   (United States)

^f Georgia Medical Care Foundation   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Heart failure; Left ventricular systolic dysfunction; Outcome assessment; Quality of health care; Readmissions

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH CARE QUALITY; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; COMORBIDITY; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HOSPITALS, COMMUNITY; HUMANS; LENGTH OF STAY; MALE; MEDICARE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT READMISSION; QUALITY INDICATORS, HEALTH CARE; SMOKING; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0141891147     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/mzg055     Document Type: Article

References (31)

1. Dicker RC, Ordin DL, Han LF, Campbell MK. Introducing the Medicare Quality of Care Surveillance System. Quality Résumé, No. 1. Baltimore, MD: Health Care Financing Administration, 1997.
2. Williams JF, Bristow MR, Fowler MB et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995; 26: 1376-1398.
3. Konstam MA, Dracup K, Baker DW et al. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical practice guideline No. 11. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, June 1994 (publication No. AHCPR 94-0612).
4. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2001; 104: 2996-3007.
5. European Society of Cardiology, Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1999; 16: 741-745.
6. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J Am Med Assoc 1995; 273: 1450-1456.
7. Philbin EF, Andreou C, Rocco TA Jr, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in heart failure in two community hospitals. Am J Cardiol 1996; 77: 832-838.
8. Croft JH, Giles WH, Roegner RH, Anda RF, Casper ML, Livengood JR. Pharmacologic management of heart failure among older adults by office-based physicians in the United States. J Fam Prac 1997; 44: 382-390.
9. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in heart failure. Arch Intern Med 1997; 157: 2242-2247.
10. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997; 157: 1103-1108.
11. Krumholz HM, Wang Y, Parent EM et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997; 157: 2242-2247.
12. Luthi JC, McClellan WM, Fitzgerald D et al. Variations among hospitals in the quality of care for Medicare beneficiaries with heart failure. Eff Clin Pract 2000; 3: 69-77.
13. Luthi JC, McClellan WM, Fitzgerald D et al. Mortality associated with the quality of care of patients hospitalized with heart failure. Intern J Qual Health Care 2002; 14: 15-24.
14. Havraneck EP, Abbrams F, Stevens E, Parker K. Determinants of mortality in elderly patients with heart failure. The role of angiotensin-converting enzyme inhibitors. Arch Intern Med 1998; 158: 2024-2028.
15. Cleland JGF, Hubbard WN, Pittard J, Poole-Wilson PA, Sutton GC. ACE inhibitors in heart failure: What dose? Br Med J 1995; 71: 65-66.
16. Physician Desk Reference (PDR), 50th ed. Montvale, NJ: Medical Economics Publications, 1996.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
18. Kleinbaum DG. Survival Analysis. A Self-Learning Text. New York: Springer Verlag, 1996.
19. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
20. Ware J. Linear models for the analysis of several measurements in longitudinal studies. Am Statist 1985; 39: 95-101.
21. Kleinbaum DG, Kupper LL, Morgenstern H. Applied regression analysis and other multivariate methods. Belmont, CA: Duxbury Press, 1988.
22. Kleinbaum DG. Logistic Regression: A Self-Learning Text. New York: Springer Verlag, 1994.
23. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley Interscience, 1989.
24. Jencks SF, Cuerdon T, Burwen DR et al. Quality of medical care delivered to Medicare beneficiaries. A profile at state and national levels. J Am Med Assoc 2000; 284: 1670-1676.
25. Krumholz HM, Parent EM, Tu N et al. Readmission after hospitalization for heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104.
26. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with heart failure. N Engl J Med 1995; 333: 1190-1195.
27. Packer M, Poole-Wilson PA, Armstrong PW et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, Lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312-2318.
28. McDermott MM, Lee P, Mehta S, Gheorghiade M. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure. Clin Cardiol 1998; 21: 261-268.
29. Luzier AB, Forrest A, Feuerstein SG, Schentag JJ, Izzo JL Jr. Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization. Am J Cardiol 2000; 86: 519-523.
30. Flather MD, Yusuf S, Kober L et al. For the ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575-1581.
31. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ. Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals. Medical Care 1992; 30: 377-391.